SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001104659-13-026779
Filing Date
2013-04-03
Accepted
2013-04-03 16:35:44
Documents
5
Period of Report
2013-05-22
Effectiveness Date
2013-04-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A a13-1825_1def14a.htm DEF 14A 595611
2 GRAPHIC g18251bc15i001.gif GRAPHIC 64933
3 GRAPHIC g18251bc15i002.gif GRAPHIC 55708
4 GRAPHIC g18251bc17i001.gif GRAPHIC 57378
5 GRAPHIC g18251bc17i002.gif GRAPHIC 50124
  Complete submission text file 0001104659-13-026779.txt   911716
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Filer) CIK: 0001130166 (see all company filings)

IRS No.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50626 | Film No.: 13739970
SIC: 2834 Pharmaceutical Preparations